| Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines LJ Macpherson, AE Dubin, MJ Evans, F Marr, PG Schultz, BF Cravatt, ... Nature 445 (7127), 541-545, 2007 | 1293 | 2007 |
| Mechanism-based profiling of enzyme families MJ Evans, BF Cravatt Chemical reviews 106 (8), 3279-3301, 2006 | 712 | 2006 |
| Overcoming mutation-based resistance to antiandrogens with rational drug design MD Balbas, MJ Evans, DJ Hosfield, J Wongvipat, VK Arora, PA Watson, ... elife 2, e00499, 2013 | 449 | 2013 |
| Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen MJ Evans, PM Smith-Jones, J Wongvipat, V Navarro, S Kim, NH Bander, ... Proceedings of the National Academy of Sciences 108 (23), 9578-9582, 2011 | 369 | 2011 |
| Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling MJ Evans, A Saghatelian, EJ Sorensen, BF Cravatt Nature biotechnology 23 (10), 1303-1307, 2005 | 276 | 2005 |
| A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index D Ulmert, R Kaboteh, JJ Fox, C Savage, MJ Evans, H Lilja, ... European Urology, 2012 | 218 | 2012 |
| 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience TA Hope, C Truillet, EC Ehman, A Afshar-Oromieh, R Aggarwal, CJ Ryan, ... Journal of Nuclear Medicine 58 (1), 81-84, 2017 | 212 | 2017 |
| CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma CH Huang, A Lujambio, J Zuber, DF Tschaharganeh, MG Doran, ... Genes & development 28 (16), 1800-1814, 2014 | 208 | 2014 |
| AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine F Lux, VL Tran, E Thomas, S Dufort, F Rossetti, M Martini, C Truillet, ... The British journal of radiology 92 (1093), 20180365, 2019 | 165 | 2019 |
| Development of a stress response therapy targeting aggressive prostate cancer HG Nguyen, CS Conn, Y Kye, L Xue, CM Forester, JE Cowan, AC Hsieh, ... Science translational medicine 10 (439), eaar2036, 2018 | 147 | 2018 |
| Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer A Afshar-Oromieh, N Debus, M Uhrig, TA Hope, MJ Evans, T Holland-Letz, ... European journal of nuclear medicine and molecular imaging 45, 2045-2054, 2018 | 145 | 2018 |
| The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation I Vivanco, D Rohle, M Versele, A Iwanami, D Kuga, B Oldrini, K Tanaka, ... Proceedings of the National Academy of Sciences 107 (14), 6459-6464, 2010 | 137 | 2010 |
| Imaging PD-L1 expression with immunoPET C Truillet, HLJ Oh, SP Yeo, CY Lee, LT Huynh, J Wei, MFL Parker, ... Bioconjugate chemistry 29 (1), 96-103, 2018 | 128 | 2018 |
| Androgen receptor upregulation mediates radioresistance after ionizing radiation DE Spratt, MJ Evans, BJ Davis, MG Doran, MX Lee, N Shah, J Wongvipat, ... Cancer research 75 (22), 4688-4696, 2015 | 121 | 2015 |
| Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity CCS Pai, DM Simons, X Lu, M Evans, J Wei, Y Wang, M Chen, J Huang, ... The Journal of clinical investigation 129 (1), 349-363, 2019 | 118 | 2019 |
| Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals BM Zeglis, JL Houghton, MJ Evans, N Viola-Villegas, JS Lewis Inorganic chemistry 53 (4), 1880-1899, 2014 | 110 | 2014 |
| Heterogeneous flare in prostate-specific membrane antigen positron emission tomography tracer uptake with initiation of androgen pathway blockade in metastatic prostate cancer R Aggarwal, X Wei, W Kim, EJ Small, CJ Ryan, P Carroll, M Cooperberg, ... European Urology Oncology 1 (1), 78-82, 2018 | 100 | 2018 |
| Annotating MYC status with 89Zr-transferrin imaging JP Holland, MJ Evans, SL Rice, J Wongvipat, CL Sawyers, JS Lewis Nature medicine 18 (10), 1586-1591, 2012 | 98 | 2012 |
| Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins AJ Martinko, C Truillet, O Julien, JE Diaz, MA Horlbeck, G Whiteley, ... Elife 7, e31098, 2018 | 87 | 2018 |
| Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen D Ulmert, MJ Evans, JP Holland, SL Rice, J Wongvipat, K Pettersson, ... Cancer Discovery, 2012 | 79 | 2012 |
Charles TruilletScientist at CEA在 cea.fr 的电子邮件经过验证
